ZyCal Bioceuticals, Inc.: A Privately owned Corporation

ZyCal Bioceuticals, Inc. is a privately owned (C-Corp) corporation whose leaders are strongly committed to its growth and success. Members of the Company’s management team are founding shareholders, committed to growing the Company’s market value.

ZyCal Bioceuticals, Inc. Position in the Market

Complimentary Alternative Medicine is a fast-growing segment of consumers’ healthcare choices. Currently one third of all Americans use some form of Alternative Medicine which include nutritional supplements.⁽¹⁾ The nutritional supplement market is valued at $22 Billion with $12.3 Billion spent annually on Vitamins, Minerals, and Specialty products.⁽¹⁾ This includes the nearly $2 Billion spent on calcium, glucosamine and chondroitin supplements for bone and joint health.⁽¹⁾ ZyCal Bioceuticals, Inc.’s leadership team believes that the Company’s strategic focus on bone & joint health, coupled with its proprietary protein-based technology, position it to achieve significant increase in shareholder value and R.O.I.

The Board of Directors of ZyCal Bioceuticals, Inc. is composed of individuals who have demonstrated success in starting-up and managing companies, raising private equity capital, creating business development opportunities with strategic corporate partners, and executing high value mergers & acquisitions. The Board possesses strong expertise in global customer-focused, value-added management.

In addition to its business leadership, the Company’s Board of Directors and Executive Management team draws its technical acumen from scientists trained at renowned research institutions including M.I.T., Harvard University, and the City University of New York. These scientists have expertise in Calcium Science, Food Science and FDA regulations.

Members of ZyCal Bioceuticals’ world-class Board hail from Fortune 500 companies and have held executive level management positions at Johnson & Johnson and EMC Corporation.

James Hobbs

Chairman of the Board

James J. Scaffidi

CEO, President, and Executive Director

Scott Hoag

Director

Porus Aria, PhD

Director